The observed positive correlation between CCL19 and activated CD8 T cells in this study reflects the host’s anti-tumor immune response, while also indicating that the balance between the tumor and immune system may be disrupted, potentially influencing BC progression. The gene discussed is CD8A; the disease is breast cancer.